Prescription Digital Therapeutics

The partnership between the alliance and the Healthware Group is aimed at harmonizing assessment criteria and regulatory pathways in Europe.

Patients using the prescription digital therapeutic saw a decrease of $3,591 in healthcare costs in the six months following treatment initiation.

The deal centers on an application that uses music and rhythm to improve patient’s gaits.

The launch is one of several digital therapeutics partnerships Pfizer has announced in recent months.

The guide is designed to help spread best practices and help healthcare decision-makers understand the benefits of digital therapeutics.

Data suggest a smartphone application can boost physical activity and relieve symptoms of chronic obstructive pulmonary disease.

High engagement was linked with high weight loss, the analysis shows.

An integrated approach not only leads to better results, but also better value, in both the short- and long-term, according to DarioHealth.

The Access to Prescription Digital Therapeutics Act, introduced in March, has the backing of the Academy of Managed Care Pharmacy.

The digital therapeutic is being marketed as an alternative to specialist-guided therapy or at-home exercises.

The company says the therapeutic will fill an unmet need with a 12-week course of therapy for irritable bowel syndrome.

A company-sponsored study found that Theranica’s digital therapeutic Nerivio resulted in a substantial reduction in intake of prescribed pharmacological medications

Prescription digital therapeutics are FDA approved and available only by prescription. Their developers are aiming to get them covered by insurers.

A panel discussion on prescription digital therapeutics identified them as a sweet spot for value-based agreements and collection of real-world evidence. But should they be paid for through the pharmacy benefit? And is there enough evidence available for payers and PBMs to make sound coverage and formulary decisions? For answers, stay tuned.

Data from clinical-grade wearables and AI-powered analytics are enabling the transition from ‘pay-per-pill’ to pay-for-value.

An $80M investment will support ventures that develop new drugs and technologies.

As digital health and therapeutic capabilities continue to grow, it is vital that managed care organizations keep one eye toward the future.